amonafide has been researched along with Leukopenia in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Allen, SL; Costanza, M; Henderson, IC; Ratain, MJ; Rosner, G; Schilsky, RL; Van Echo, DA | 1 |
| Mick, R; Ratain, MJ | 1 |
| Berezin, F; Janisch, L; Kut, M; Mick, R; Ratain, MJ; Schilsky, RL; Vogelzang, NJ | 1 |
| Asbury, R; Ball, H; Blessing, JA; Podczaski, E | 1 |
| Bonnet, JD; Braun, TJ; Crowley, J; Hanson, KH; Keppen, M; Salmon, SE | 1 |
| Depisch, D; Dittrich, C; Gisslinger, H; Haider, K; Kornek, G; Linkesch, W; Scheithauer, W | 1 |
| Berezin, F; Janisch, L; Mick, R; Ratain, MJ; Schilsky, RL; Smiddy, J; Williams, SF | 1 |
5 trial(s) available for amonafide and Leukopenia
| Article | Year |
|---|---|
Population pharmacodynamic study of amonafide: a Cancer and Leukemia Group B study.
Topics: Acetylation; Adenine; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Breast Neoplasms; Female; Humans; Imides; Isoquinolines; Leukopenia; Lymphoma, Non-Hodgkin; Metabolic Clearance Rate; Middle Aged; Multivariate Analysis; Naphthalimides; Organophosphonates; Racial Groups; Regression Analysis; Serum Albumin; United States | 1995 |
Bootstrap validation of pharmacodynamic models defined via stepwise linear regression.
Topics: Acetylation; Adenine; Aging; Female; Humans; Imides; Isoquinolines; Leukocyte Count; Leukopenia; Male; Models, Statistical; Naphthalimides; Organophosphonates; Regression Analysis; Selection Bias; Sex Factors | 1994 |
A phase II trial of amonafide in patients with mixed mesodermal tumors of the uterus: a Gynecologic Oncology Group study.
Topics: Adenine; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Female; Humans; Imides; Isoquinolines; Leukopenia; Middle Aged; Mixed Tumor, Mesodermal; Naphthalimides; Organophosphonates; Thrombocytopenia; Uterine Neoplasms | 1998 |
Evaluation of amonafide in refractory and relapsing multiple myeloma: a Southwest Oncology Group study.
Topics: Adenine; Adult; Aged; Antineoplastic Agents; Blood Cell Count; Drug Resistance; Female; Granulocytes; Humans; Imides; Isoquinolines; Leukopenia; Male; Middle Aged; Multiple Myeloma; Naphthalimides; Organophosphonates; Recurrence; Thrombocytopenia | 1991 |
Phase II study of amonafide in advanced breast cancer.
Topics: Adenine; Adult; Aged; Antineoplastic Agents; Breast Neoplasms; Cardiomyopathies; Drug Evaluation; Female; Humans; Imides; Infusions, Intravenous; Isoquinolines; Leukopenia; Middle Aged; Naphthalimides; Nausea; Organophosphonates | 1991 |
2 other study(ies) available for amonafide and Leukopenia
| Article | Year |
|---|---|
Individualized dosing of amonafide based on a pharmacodynamic model incorporating acetylator phenotype and gender.
Topics: Acetylation; Adenine; Adult; Antineoplastic Agents; Drug Administration Schedule; Female; Humans; Imides; Isoquinolines; Leukocyte Count; Leukopenia; Male; Middle Aged; Models, Biological; Naphthalimides; Organophosphonates; Phenotype; Prospective Studies; Sex Factors | 1996 |
Paradoxical relationship between acetylator phenotype and amonafide toxicity.
Topics: Acetylation; Adenine; Antineoplastic Agents; Body Weight; Female; Humans; Imides; Isoquinolines; Leukopenia; Male; Middle Aged; Naphthalimides; Organophosphonates; Phenotype; Prospective Studies | 1991 |